Literature DB >> 31628587

Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?

Mehdi Toghi1, Sara Bitarafan2.   

Abstract

Entities:  

Year:  2019        PMID： 31628587     DOI： 10.1007/s11481-019-09881-y

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN： 1557-1890            Impact factor:   4.147


× No keyword cloud information.
  7 in total

Review 1.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

Review 2.  The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.

Authors:  Ellen M Mowry; Justin D Glenn
Journal:  Neurol Clin       Date:  2018-02       Impact factor: 3.806

3.  Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.

Authors:  Dennis Chan; Sophie Binks; Jennifer M Nicholas; Chris Frost; M Jorge Cardoso; Sebastien Ourselin; David Wilkie; Richard Nicholas; Jeremy Chataway
Journal:  Lancet Neurol       Date:  2017-06-07       Impact factor: 44.182

4.  Statins: antimicrobial resistance breakers or makers?

Authors:  Humphrey H T Ko; Ricky R Lareu; Brett R Dix; Jeffery D Hughes
Journal:  PeerJ       Date:  2017-10-24       Impact factor: 2.984

5.  Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.

Authors:  Jose A Caparrós-Martín; Ricky R Lareu; Joshua P Ramsay; Jörg Peplies; F Jerry Reen; Henrietta A Headlam; Natalie C Ward; Kevin D Croft; Philip Newsholme; Jeffery D Hughes; Fergal O'Gara
Journal:  Microbiome       Date:  2017-08-09       Impact factor: 14.650

Review 6.  Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?

Authors:  Hideo Ohira; Wao Tsutsui; Yoshio Fujioka
Journal:  J Atheroscler Thromb       Date:  2017-05-27       Impact factor: 4.928

Review 7.  The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue.

Authors:  Trevor O Kirby; Javier Ochoa-Repáraz
Journal:  Med Sci (Basel)       Date:  2018-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.